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http://www.biomedcentral.com/1471-2369/14/27RESEARCH ARTICLE Open AccessVascular calcification on plain radiographs is
associated with carotid intima media thickness,
malnutrition and cardiovascular events in dialysis
patients: a prospective observational study
Won Suk An1,2 and Young Ki Son1*Abstract
Background: Vascular calcification (VC) and carotid intima media thickness (CIMT) are strongly associated with
cardiovascular (CV) disease. We hypothesized that significant VC on plain radiographs is associated with CIMT and
CV events in dialysis patients. In addition, we evaluated risk factors for VC progression on plain radiographs in
dialysis patients.
Methods: In this 2-year observational, prospective study, 67 dialysis patients were included. We checked plain
radiographs at baseline and after 2 years. Laboratory tests and malnutrition score were obtained at baseline, after
12 months, and after 24 months.
Results: The mean age of patients was 56.3 ± 10.3 years and duration of dialysis was 41.3 ± 34.5 months. The
prevalence of significant VC was 61.2% and the prevalence of carotid artery atheromatous plaques was 55.6%. Mean
CIMT, malnutrition scores, CRP level and prevalence of carotid atheromatous plaques were significantly higher in
patients with significant VC. Serum albumin and total iron binding capacity were significantly lower in patients with
significant VC compared to patients without significant VC. During a mean observational period of 22 months,
patients without significant VC showed lower CV events by the Kaplan-Meyer method (p = 0.010). Progression of VC
was found in 35.7% among 56 patients followed up. Hemoglobin after 24 months was an independent factor for
progression of VC (Exp(B) = 0.344, 95% Confidence Interval = 0.13 – 0.96, p = 0.034).
Conclusions: Significant VC on plain radiograph was associated with CIMT, malnutrition, inflammation, and CV
events in dialysis patients. Conditions which increase hemoglobin level may retard progression of VC in dialysis
patients.
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Cardiovascular disease is a major cause of morbidity and
mortality in dialysis patients [1]. Vascular calcification
(VC) is highly correlated with cardiovascular disease
(CVD) and frequently detected in patients with chronic
kidney disease (CKD) [2]. VC scores ≥ 3 on plain radio-
graphs of the pelvis and hands are associated with coron-
ary artery disease (CAD) in hemodialysis (HD) patients* Correspondence: kidney@dau.ac.kr
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reproduction in any medium, provided the or[3]. It was found that an abdominal aortic calcification
(AAC) score of greater than 5 is related with the risk of
CVD in dialysis patients [4]. The presence of medial artery
calcification on plain radiography of the feet is also
associated with prevalence of CAD and peripheral ar-
tery disease (PAD) in HD patients [5,6]. Therefore,
these significant VCs on plain radiographs can be a
vital source of information for CVD and cardiovascular
mortality in dialysis patients.
Myocardial infarction and stroke were increased by the
0.1 mm increase of carotid intima media thickness (CIMT) in
the meta-analysis [7]. Thoracic aortic calcification detected byLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ity of CIMT in the multi-ethnic study [8]. CIMT was greater
in HD patients compared to the control group [9]. The pres-
ence of carotid plaques is also important risk factor for CVD
and is common in HD patients compared to general popula-
tion [10,11]. Valvular calcification has shown an association
with inflammation, carotid atherosclerosis and arterial calcifi-
cation in end-stage renal disease [12]. However, there is no
previous study about the relationship between VC on plain
radiograph and carotid intima media thickness (CIMT). Mal-
nutrition is another important factor related to CVD and
mortality in dialysis patients. In addition, malnutrition was
related to valvular calcification and low fetuin-A levels which
are marker of VC inhibition [13]. Still, there is no re-
port about the association between VC on plain radio-
graphs and malnutrition. VC on plain radiographs will
be a useful clinical tool if those relationships are
proven. Therefore, we hypothesized that significant VC
on plain radiographs is associated with CIMT, malnu-
trition and cardiovascular events for two-year observa-
tional periods in dialysis patients. In addition, we
evaluated risk factors including malnutrition for VC
progression on plain radiographs in dialysis patients.
Methods
Patients
In this 24 month prospective observational study, we
included dialysis patients aged 20 to 80 years and treated
with dialysis for 6 or more months at Dong-A University
dialysis center. Patients with a history of hospital admis-
sion due to CVD within 3 months, history of active in-
fection within 3 months, malignancy and liver cirrhosis
with Child class B or C were excluded. Finally we
recruited 67 dialysis patients (41 HD patients and 26
peritoneal dialysis (PD) patients, 49.3% diabetes) who
want to participate. Informed consent was obtained from
all enrolled patients, and the study was approved by the
Dong-A University Hospital Institutional Review Board.
The enrolled HD patients received regular HD three
times weekly using bicarbonate-based dialysate and poly-
sulfone dialyzers (Fresenius, Bad Homburg, Germany).
The enrolled PD patients received 4 exchanges per day
using a standard regimen (8 L/day). All enrolled patients
were interviewed and underwent a clinical examination
at the initiation of the study. Their medical history and
outpatient records were also evaluated in detail. We
defined cardiovascular events as any one finding among
the following findings: ischemic heart disease that needs
treatment; sudden cardiac death; acute heart failure;
PAD; hemorrhagic stroke; ischemic stroke.
Vascular calcification
We checked the plain radiographs of the feet, hands,
pelvis, and lateral lumbar spine and estimated the VCscores with previously reported methods at baseline and
after 24 months. The abdominal aortic calcification
(AAC) was graded using a previously reported system in
which the location and severity of calcification deposits
at each lumbar vertebral segment (Lumbar 1–Lumbar 4)
were evaluated [4]. It has been reported that an AAC ≥ 5
increases the risk of CVD. VC scores of the pelvis and
hands were evaluated in plain radiographic films. The
radiographic films of the pelvis and hands were divided
into 4 sections by two imaginary lines. The final score
was the sum of all sections, ranging from 0 to 8. In a
previous study, receiver operating characteristic curve
analysis identified a VC score ≥ 3 as the best cut-off
value associated with cardiovascular motility and cardio-
vascular events [3]. On radiographs of the feet, the score
is 0 when medial artery calcification on plain radio-
graphs of feet is absent, and the score is 1 when VC is
present. Each VC is a useful predictor for CVD. We
checked several plain radiographs and evaluated several
VC sites on plain radiographs. And we defined signifi-
cant VC as any one finding among the following findings
on plain radiographs: AAC score ≥ 5; VC score of the
hands and pelvis ≥ 3; medial artery calcification of the
feet. We defined VC progression on plain radiographs as
any one finding among the following findings on plain
radiographs: increases of AAC score ≥3; increases of VC
score of the hands and pelvis ≥1; newly developed med-
ial artery calcification of the feet. AXIOM Aristors MX/
VX (SIEMENS, Erlangen, Germany) radiographic equip-
ment with a digital imaging system was used (exposure
conditions, 45–50 kVp [4mAs]). Two nephrologists indi-
vidually decided VC scores on plain radiographs without
information from patients. Consensus was reached on
the interpretation of all radiographs.
Assessment of CIMT
Carotid Doppler ultrasonography was performed by a
single operator and CIMT was measured; the operator
was blinded about the history and laboratory findings of
the patients. CIMT was defined as the distance between
the leading edge of the first bright line and the leading
edge of the second bright line containing intima-media
interface and media-adventitia interface on the posterior
wall of the both common carotid arteries (CCA). Measure-
ments were taken over a 10-mm length using a B-mode
high-resolution ultrasonography system (Philips Sonos
5500, Andover, MA, USA). When an atherosclerotic
plaque was present at the measurement site, it was
included in the measurement of the CIMT. Athero-
sclerotic plaques were defined as a protrusion into the
lumen adding 50% to the thickness of the surrounding
intima-media or maximal thickness of 1.5 mm in the
both CCA. We used the maximal thickness of the
intima-media complex as CIMT in this study.
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Laboratory tests including hemoglobin (Hb), calcium,
phosphorous, intact parathyroid hormone, serum albu-
min, total iron-binding capacity (TIBC), alkaline phos-
phatase, C-reactive protein (CRP), total cholesterol,
triglycerides, low-density lipoprotein-cholesterol, high-
density lipoprotein cholesterol (HDL), blood urea nitro-
gen and creatinine were obtained using fasting blood
samplings. HbA1c was determined in diabetic patients.
Blood samples and body mass index (BMI) were taken
before HD and before Carotid Doppler ultrasonography
in PD patients.
Assessment of malnutrition
We used Comprehensive Malnutrition Inflammation
Scores (MIS) to assess the status of malnutrition [14].
Seven components of Dialysis Malnutrition Score were
revised to comprehensive MIS by adding three new
items: BMI, serum albumin level, and TIBC [15]. The
other 7 components of Comprehensive MIS are dry
weight, dietary intakes, gastrointestinal symptoms, func-
tional capacity, comorbidity including number of years
on dialysis, loss of subcutaneous fat and muscle wasting.
Comprehensive MIS has 10 components, each with four
levels of severity, from 0 (normal) to 3 (severely abnor-
mal). The sum of all 10 comprehensive MIS components
ranges from 0 (normal) to 30 (severely malnourished); a
higher score reflects a more severe degree of malnutri-
tion and inflammation.
We evaluated body fat composition by using bioelec-
trical impedance analysis at baseline and after 24 months.
Statistical analysis
We initially decided on a minimum sample size of 80
because the minimum correlation coefficient was 0.22
between VC on plain radiographs and CAD, based on
our previous study. Therefore, we observed and evalu-
ated cardiovascular events including CAD because we
recruited a total of 67 dialysis patients in this study. All
data are presented as the means ± SD. The non-
parametric Mann–Whitney U test was used to compare
baseline data according to significant VC, each VC scor-
ing method and progression of VC on plain radiographs.
The difference in frequency was tested using Pearson’s
chi-square analysis. Spearman analysis was used for cor-
relation analysis. The non-parametric Wilcoxon exact
rank sum test was used to compare baseline data to
12 months data, and 24 months data. The non-
parametric Wilcoxon exact rank sum test was also used
to compare 12 months data to 24 months data. Cardio-
vascular events, coronary events and cardiovascular
deaths according to significant VC and each VC scoring
method were analyzed by Kaplan-Meier models using
the log-rank test. Univariate and mulvariate logisticregression analysis was applied to determine the factors
independently associated with progression of VC on
plain radiographs. The adjusted variables included age,
diabetes, albumin at 24 months, CRP at 24 months and
Hb at 24 months. We rejected null hypotheses of no dif-
ference if p-values were less than 0.05. All statistical cal-
culations were performed with SPSS software (version
19.0; SPSS Inc., Chicago, IL, USA).Results
Clinical and laboratory findings according to significant VC
The mean age of enrolled dialysis patients was 56.3 ±
10.3 years and the duration of dialysis was 41.3 ±
34.5 months. The prevalence of significant VC was
61.2% and the prevalence of carotid artery atheroscler-
otic plaques was 55.6%. The baseline clinical findings of
patients according to significant VC on plain radio-
graphs are listed in Table 1. Those with significant VC
were older, and had higher prevalence of diabetes. Mean
CIMT (right: p = 0.006, left: p = 0.001), MIS (p = 0.007),
CRP levels and prevalence of carotid artery atheroscler-
otic plaques (p = 0.003) were significantly higher in
patients with significant VC compared to patients with-
out significant VC (Table 1). Serum albumin and total
iron binding capacity were significantly lower in patients
in patients with significant VC compared to patients
without significant VC. There were no significant differ-
ences of body fat composition according to significant
VC. Mean levels of intact parathyroid hormone, calcium,
and phosphorous were not significantly different in
patients with and without significant VC. Left CIMT
(r = 0.466, p = 0.011), right CIMT (r = 0.378, p = 0.043),
MIS (r = 0.340, p = 0.006) and prevalence of atheroma-
tous plaques (r = 0.424, p = 0.024) were significantly
correlated with significant VC.Clinical and laboratory findings according to each VC
scoring method
The prevalence of diabetes, age, both CIMT and CRP
were significantly higher in patients with medial artery
calcification of the feet than patients without medial ar-
tery calcification of the feet. TIBC and HDL cholesterol
were significantly lower in patients with medial artery
calcification of the feet than patients without medial
artery calcification of the feet. There were no signifi-
cant differences of prevalence of carotid artery athero-
sclerotic plaques, MIS and albumin between the
groups with and without medial artery calcification of
the feet (Table 2).
The prevalence of carotid artery atherosclerotic pla-
ques, age and left CIMT were significantly higher in
patients with hands and pelvis VC score ≥ 3 than
patients with hands and pelvis VC score < 3. HDL was
Table 1 Characteristics of study population according to
significant vascular calcification






Age (years) 59.6 ± 9.2 51.12 ± 10.0 0.001
Male, n (%) 13(38.2%) 9(40.9%) 1.000
Diabetes, n (%) 26(75.8%) 8(24.2%) 0.015
HD/PD, n 26/15 15/11 0.415
CIMT, Right. (mm) 0.97 ± 0.19 0.77 ± 0.21 0.006
CIMT, Left (mm) 0.97 ± 0.21 0.74 ± 0.13 0.001
Carotid atheroma (%) 73.9 23.1 0.003
MIS 4.6 ± 2.7 3.3 ± 52.7 0.007
Dialysis duration (months) 44.6 ± 32.9 36.1 ± 37.1 0.333
Body mass index (kg/m2) 23.6 ± 3.0 23.1 ± 3.1 0.674
Hemoglobin (g/dL) 10.4 ± 1.0 10.5 ± 1.2 0.867
PTH (pg/mL) 295.5 ± 264.8 411.9 ± 343.3 0.158
Calcium (mg/dL) 8.8 ± 0.7 8.7 ± 0.7 0.811
Phosphorous (mg/dL) 4.7 ± 1.5 4.8 ± 1.5 0.719
Creatinine (mg/dL) 12.5 ± 16.2 10.3 ± 2.8 0.857
Albumin (g/dL) 3.9 ± 0.3 4.0 ± 0.3 0.035
TIBC (ug/dl) 245.0 ± 46.7 288.6 ± 33.7 0.017
CRP (mg/dL) 0.9 ± 1.5 0.2 ± 0.4 0.000
Abbreviations: HD, hemodialysis; PD, peritoneal dialysis; CIMT, carotid intima-
media thickness; MIS, malnutrition-inflammation score; PTH, parathyroid
hormone; TIBC, total iron binding capacity; CRP, C-reactive protein.
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score ≥ 3 than patients with hands and pelvis VC score < 3.
The prevalence of carotid artery atherosclerotic plaques,
age, left CIMT, MIS and CRP were significantly higher in
patients with AAC ≥ 5 than patients with AAC < 5. Serum
albumin was significantly lower in patients with AAC ≥ 5







Age (years) 60.0 ± 9.8* 53.4 ± 9.9 58.8 ± 1.0
DM (%) 21 (72.4)* 12 (31.6) 20 (74.1)
CIMT, Right (mm) 1.0 ± 0.2* 0.8 ± 0.2 1.0 ± 0.2
CIMT, Left (mm) 1.0 ± 0.3* 0.8 ± 0.2 1.0 ± 0.3*
Carotid atheroma (%) 73.3 42.9 86.7*
MIS 4.6 ± 2.9 3.8 ± 2.6 4.4 ± 2.9
HDL (mg/dL) 37.5 ± 10.9* 43.3 ± 10.3 38.0 ± 11.4
CRP (mg/dL) 1.1 ± 1.8* 0.3 ± 0.4 0.8 ± 1.5
TIBC (ug/dl) 231.6 ± 41.3* 279.6 ± 41.0 247.7 ± 42
Albumin (g/dL) 3.9 ± 0.3 4.0 ± 0.3 3.9 ± 0.3
Abbreviations: VC, vascular calcification; DM, diabtes mellitus; CIMT, carotid intima-m
lipoprotein cholesterol; TIBC, total iron binding capacity; CRP, C-reactive protein.
*p < 0.05; significant different from patients with VC(−) or lower score in each groupdifferences of prevalence of diabetes, HDL cholesterol and
TIBC between the groups according AAC ≥ 5 or < 5.
Nineteen (42.2%) of 45 patients with AAC scores < 5
had significant VC score on other parts, 14 of 40
patients (35.0%) with hand and pelvis VC score < 3 had
significant VC score on other parts, and 12 (31.6%) of 38
patients without medial artery calcification of the feet
had significant VC score on other parts.
VC progression
VC progression on plain radiographs was found in 20
patients (35.7%, 47.6% of PD patients and 29.6% of HD
patients) among 56 patients followed up. Increases of
AAC score ≥3 in 12 patients, increases of VC score of
hands & pelvis ≥1 in 3 patients and newly developed
medial artery calcification of the feet in 2 patients were
found. VC progressions based on two different VC scor-
ing methods was also found in two patients. Three dif-
ferent VC progressions were even found in one patient.
Fourteen of 20 patients (70%) who showed progression
of VC throughout the study already had a significant VC
at baseline and 18 of 36 patients (50%) who showed no
progression of calcification patients had a significant VC
at baseline. During follow-up period, Hb levels were sig-
nificantly increased according to elapsed time in patients
who did not show VC progression on plain radiographs
(10.3 ± 1.0 g/dL at baseline, 10.9 ± 1.1 g/dL after 1 year,
11.4 ± 1.3 g/dL after 2 years) (Figure 1). Erythropoietin
dose per month was not significantly higher in patients
who showed VC progression on plain radiographs (Dar-
bepoetin alpha: 282.9 ± 130.6 mcg/month, erythropoi-
etin-beta: 49224.1 ± 39854.1 IU/month [patients with VC
progression] vs. Darbepoetin alpha: 238.6 ± 210.5 mcg/
month, erythropoietin-beta: 49980.2 ± 33146.0 IU/month,
[patients without VC progression]). There was no signifi-




scores <3 (n = 40)
AAC scores ≥5
(n = 22)
AAC scores < 5
(n = 45)
54.6 ± 10.3 60.6 ± 7.4* 54.2 ± 11.0
* 13 (32.5) 13 (59.1) 20 (44.4)
0.8 ± 0.2 1.0 ± 0.2 0.8 ± 0.2
0.8 ± 0.1 1.0 ± 0.3* 0.8 ± 0.2
33.3 92.3* 34.8
3.9 ± 2.7 5.0 ± 3.0* 3.7 ± 2.5
* 42.7 ± 10.3 40.8 ± 11.0 40.8 ± 11.0
0.5 ± 1.1 0.8 ± 1.3* 0.5 ± 1.2
.7 273.6 ± 46.9 253.3 ± 50.7 270.4 ± 44.1
3.9 ± 0.3 3.8 ± 0.3* 4.0 ± 0.3
edia thickness; MIS, malnutrition-inflammation score; HDL, high density
.
Figure 1 Hemoglobin levels according to elapsed time in patients showed vascular calcification non-progression (a) and vascular
calcification progression (b) on plain radiographs.
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gression] vs. 3251.7 ± 1027.4 mg/week [patients without
VC progression]). HDL (41.3 ± 11.6 mg/dL vs. 47.4 ±
13.9 mg/dL) and serum albumin levels (3.96 ± 0.27 g/dL vs.
4.14 ± 0.33 g/dL) were also significantly increased at the
end of follow-up period compared to baseline in
patients who did not show VC progression. Hb levels
after 24 months were an independent factor for VC
progression on plain radiographs (Exp(B) = 0.344, 95%
Confidence Interval = 0.13 – 0.96, p = 0.034)(Table 3).
Cardiovascular events according to VC
During an observational period of 22 months, there were
6 cardiovascular deaths (three sudden cardiac deaths,
two fatal myocardial infarctions and one intracerebral
hemorrhage) among 8 deaths. There was no significant
difference of cardiovascular mortality by significant VC
on the plain radiographs. CAD was developed in 13
patients (19.4%) and 17 patients (25.4%) suffered from
cardiovascular events. Significantly fewer cardiovascular
events (p = 0.010) were observed in patients withoutTable 3 Logistic regression analysis for progression of
vascular calcification
Univariate Multivariate
Variable Exp(B) (95% CI) p value Exp(B) (95% CI) p value
Age 1.023(0.97-1.08) 0.435 0.951(0.85-1.06) 0.375
Diabetes 0.584(0.19-1.76) 0.340 0.931(0.17-5.09) 0.934
Albumin at
24 months
0.175(0.03-1.24) 0.081 0.517(0.04-6.78) 0.615
CRP at 24 months 1.575(0.54-4.63) 0.409 3.640(0.20-65.31) 0.380
Hb at 24 months 0.308(0.11-0.88) 0.029 0.344(0.13-0.96) 0.034
Abbreviations: CI, Confidence Interval; CRP, C-reactive protein; Hb,
Hemoglobin.significant VC compared to patients with significant VC
(Figure 2). In each VC scoring method, significantly
lower cumulative cardiovascular events were observed in
patients without medial artery calcification of the feet
(log rank = 6.8; p = 0.009), with hands and pelvis VC
score < 3 (log rank = 4.1; p = 0.04) and with AAC score < 5
(log rank = 4.5; p = 0.034) compared to patients with med-
ial artery calcification of the feet or with higher VC scores
(Figures 2, 3). Coronary events were lower, but not signifi-
cant, in patients without significant VC compared to
patients with significant VC (p = 0.07). In each VC scoring
method, coronary events were not significantly different
in patients without medial artery calcification of the feet
(p = 0.135), with hands and pelvis VC score < 3 (p = 0.340)
and with AAC score < 5 (p = 0.097) compared to patients
with medial artery calcification of the feet or with higher
VC scores.
Discussion
In this study, we observed that carotid intima media was
thicker in patients with any one significant VC than in
patients without significant VC. The same results were
observed in patients who showed meaningful VC accord-
ing to each VC scoring method. Furthermore, cardiovas-
cular events were more frequent in patients with any one
significant VC than patients without significant VC for the
two-year observation period. It is of note that both signifi-
cant VC defined by using three VC scoring methods and
medial artery calcification by checking both feet AP view
are more reliable predictors for cardiovascular events than
any other single VC scoring method. We also found that
VC evaluation on plain radiographs by single method
overlooked over 30% of other significant VC sites in dialy-
sis patients. These results suggest that we can explain car-
diovascular risks to the patients not only with single VC
Figure 2 Cardiovascular events free survival according to significant vascular calcification (a), medial artery calcification of the feet (b).
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defined by using several VC scoring methods. VC scoring
methods on plain radiographs are less quantitative, but
those are cheaper diagnostic methods than VC scores
using computed tomography (CT). To our knowledge,
this is the first observational study to compare clinical
findings according to several VC scoring methods on plain
radiographs and to prove the necessity of checking several
VC sites for evaluation of possible CVD.
Vascular calcification and progression of aortic arch
was associated with higher risk of mortality [16]. VC
progression on the plain radiographs was found in the
one third of patients followed for the short period of
two years in our study. It is of note that VC of abdom-
inal aortic area progressed in 60% of patients with VC
progression, and VC of other sites also progressed inFigure 3 Cardiovascular events free survival according to AAC score ≥40% of patients with VC progression. In addition, VC
progression of multiple sites on the plain radiographs
was found in 15% of patients with VC progression.
Therefore, VC evaluation by using several plain radio-
graphs is more useful than using single VC scoring
method for close monitoring of VC progression. VC at
baseline has proven to be one of the most important factors
for VC progression in several studies using CT [17-20].
Patients with a zero coronary artery calcification (CAC)
score at baseline showed no progress to a CAC Score >30
over 18 months [18]. However, 30% of patients who showed
VC progression had no significant VC at baseline in our
present study. Consistent with our results, 32.6% among
patients with an initial calcification score of zero on CT of
superficial femoral artery showed VC development in a pre-
vious study [19]. Based on these results, we can suggest that5 (a) and hands and pelvis VC score ≥ 3 (b).
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tinuously compatible with VC formation or changed to con-
ditions for VC formation.
Chronic inflammation and oxidative stress prominent
in uremic status are related to VC [21]. Older age, dysli-
pidemia and diabetes are also important factors affecting
on VC formation [22]. Low HDL was associated with
rapid progression of CAC determined by EBCT in HD
patients [22]. In this present study, HDL was signifi-
cantly lower in patients with medial artery calcification
of the feet or hands and pelvis VC score ≥ 3 on the
plain radiographs. In addition, HDL was significantly
increased compared to baseline levels in patients who
did not show VC progression. However, there was no
difference of HDL according to significant calcification
of abdominal aorta in this study. Based on these
results, HDL is closely related with VC formation in
small to medium vessels. The prevalence of diabetes
was significantly higher in patients with medial artery
calcification of feet and hands and pelvis VC score ≥ 3,
but there was no difference of diabetes according to
significant abdominal aortic calcification. These results
partially support that different pathogenic mechanisms
may be related to VC locations. Further studies are ne-
cessary to elucidate the pathogenesis on VC formation
according to vessel size or location.
Anemia is associated with high mortality in patients
who receive maintenance dialysis treatment and
increased survival was associated with rising hemoglobin
over a 2-year observation period [23,24]. Mortality can
be also affected by erythropoietin responsiveness in HD
patients [25]. In addition, hemoglobin reflects well several
conditions including malnutrition in dialysis patients. We
found increasing levels of hemoglobin over a 2-year obser-
vation period in patients with non-progression of VC,
which was not related to the doses of supplemental iron
or erythropoietin. This may indicate that conditions in
favour of increase in hemoglobin level, such as lack of in-
flammation and oxidative stress, may be also supportive
against VC. Albumin and MIS were associated with sig-
nificant VC and AAC score ≥ 5 and increased albumin
was associated with VC progression in the present study.
These results suggest that nutritional status reflecting sev-
eral conditions may affect VC. However, these conditions
may be different with environment with high and ad-
equate hemoglobin levels just by blood transfusion or high
erythropoietin supplementations without correction of in-
flammation, oxidative stress and malnutrition. Further
investigations are necessary to elucidate the effect of
hemoglobin correction on preventing VC progression.
A broader interpretation of these study results in dialysis
patients is limited by the small sample size and short ob-
servational period. Despite these limitations, we demon-
strated that significant VC defined by using several VCscoring methods was useful tool for predicting CV events
and it was related with CIMT and malnutrition.
Conclusions
In conclusion, significant VC on plain radiograph was
associated with CIMT, malnutrition, inflammation, and
CV events in dialysis patients. Conditions which increase
hemoglobin level may retard progression of VC on the
plain radiograph in dialysis patients.
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